Renata Marchewka

Papers

2

Total Citations

41

H-Index

2

About

Dr. Renata Marchewka is a pioneering researcher in neurorehabilitation, with a focused expertise in robotic-assisted therapy for post-viral fatigue syndromes. Her most impactful work addresses the urgent, long-term consequences of COVID-19, specifically targeting patients suffering from Post-Coronavirus Fatigue Syndrome. Dr. Marchewka’s major contributions lie in demonstrating the safety and feasibility of integrating EMG-driven rehabilitation robots into clinical care for this population. Her 2022 pilot study (22 citations) established the foundational protocol for using these devices with post-COVID patients, while her subsequent 2023 trial (19 citations) provided critical comparative data, showing that combining traditional neurological rehabilitation with robotic assistance yields superior outcomes for individuals transitioning from intensive care. By bridging the gap between advanced robotics and clinical neurology, Dr. Marchewka has not only validated a novel treatment pathway for a debilitating new syndrome but has also set a benchmark for future research in technology-enhanced recovery. Her work is essential reading for anyone exploring the intersection of rehabilitation engineering and post-viral neurology.

Research Focus

Key Achievements

2
H-Index
2
Papers
41
Total Citations
21
Avg Citations/Paper
🏆 Most Cited Paper
Application of an EMG-Rehabilitation Robot in Patients with Post-Coronavirus Fatigue Syndrome (COVID-19)—A Feasibility Study
22 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 10

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago